Decitabine: a promising epi-immunotherapeutic agent in solid tumors
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Decitabine: a promising epi-immunotherapeutic agent in solid tumors
Authors
Keywords
-
Journal
Expert Review of Clinical Immunology
Volume 11, Issue 3, Pages 363-375
Publisher
Informa UK Limited
Online
2015-01-12
DOI
10.1586/1744666x.2015.1002397
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alterations of immune response of non-small cell lung cancer with Azacytidine
- (2015) John Wrangle et al. Oncotarget
- Nonclinical pharmacokinetics and metabolism of EPZ-5676, a novel DOT1L histone methyltransferase inhibitor
- (2014) Aravind Basavapathruni et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors
- (2014) Jing Nie et al. CANCER LETTERS
- A phase I study of decitabine with pegylated interferon α-2b in advanced melanoma: impact on DNA methylation and lymphocyte populations
- (2014) E. R. Plimack et al. INVESTIGATIONAL NEW DRUGS
- Hypomethylating Agent 5-Aza-2′-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models
- (2014) Katia Mangano et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Epigenetic Regulation of Foxp3 Expression in Regulatory T Cells by DNA Methylation
- (2014) G. Lal et al. JOURNAL OF IMMUNOLOGY
- Epigenetic drugs as immunomodulators for combination therapies in solid tumors
- (2014) Luca Sigalotti et al. PHARMACOLOGY & THERAPEUTICS
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Decitabine facilitates immune recognition of sarcoma cells by upregulating CT antigens, MHC molecules, and ICAM-1
- (2014) Deepa Kolaseri Krishnadas et al. TUMOR BIOLOGY
- Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samples
- (2014) David J Stewart et al. Clinical Epigenetics
- Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer
- (2014) K. Odunsi et al. Cancer Immunology Research
- DNA methylation and nucleosome occupancy regulate the cancer germline antigen geneMAGEA11
- (2013) Smitha R James et al. Epigenetics
- A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer
- (2013) I. Garrido-Laguna et al. INVESTIGATIONAL NEW DRUGS
- The future of epigenetic therapy in solid tumours—lessons from the past
- (2013) Nilofer Azad et al. Nature Reviews Clinical Oncology
- What Lies Within: Novel Strategies in Immunotherapy for Non-Small Cell Lung Cancer
- (2013) P. M. Forde et al. ONCOLOGIST
- Concise Drug Review: Azacitidine and Decitabine
- (2013) E. J. B. Derissen et al. ONCOLOGIST
- Low Dose Decitabine Treatment Induces CD80 Expression in Cancer Cells and Stimulates Tumor Specific Cytotoxic T Lymphocyte Responses
- (2013) Li-Xin Wang et al. PLoS One
- Potential role of 5-Aza-2′-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer
- (2013) Viswanath Gunda et al. SURGERY
- Inhibiting cardiac allograft rejection with interleukin-35 therapy combined with decitabine treatment in mice
- (2013) Hao Guo et al. TRANSPLANT IMMUNOLOGY
- Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis
- (2012) H. A. Tawbi et al. ANNALS OF ONCOLOGY
- 5-aza-2′-Deoxycytidine Enhances the Radiosensitivity of Breast Cancer Cells
- (2012) Li Wang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Phase I study of 5-aza-2′-deoxycytidine in combination with valproic acid in non-small-cell lung cancer
- (2012) B. F. Chu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice
- (2012) Pierre L. Triozzi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Decitabine and Vorinostat Cooperate To Sensitize Colon Carcinoma Cells to Fas Ligand-Induced Apoptosis In Vitro and Tumor Suppression In Vivo
- (2012) D. Yang et al. JOURNAL OF IMMUNOLOGY
- Epigenetic Modulation to Enable Antigen-specific T-cell Therapy of Colorectal Cancer
- (2012) Jeffrey Chou et al. JOURNAL OF IMMUNOTHERAPY
- Cancer/testis antigens and urological malignancies
- (2012) Prakash Kulkarni et al. Nature Reviews Urology
- Complete Remission Following Decitabine/Dendritic Cell Vaccine for Relapsed Neuroblastoma
- (2012) D. K. Krishnadas et al. PEDIATRICS
- NYESO-1/LAGE-1s and PRAME Are Targets for Antigen Specific T Cells in Chondrosarcoma following Treatment with 5-Aza-2-Deoxycitabine
- (2012) Seth M. Pollack et al. PLoS One
- Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients
- (2012) K. Odunsi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer testis antigens
- (2012) Anil Suri et al. OncoImmunology
- Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2′-Deoxycytidine
- (2011) Mengyong Yan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing
- (2011) Lei Bao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Expression and Immunotherapeutic Targeting of the SSX Family of Cancer-Testis Antigens in Prostate Cancer
- (2011) H. A. Smith et al. CANCER RESEARCH
- Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas
- (2011) Anastasios Stathis et al. CLINICAL CANCER RESEARCH
- Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo
- (2011) Oscar Alcazar et al. INTERNATIONAL JOURNAL OF CANCER
- Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway
- (2011) Veerauo V Konkankit et al. Journal of Translational Medicine
- A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer
- (2010) Fang Fang et al. CANCER
- The DNA demethylating agent 5-aza-2′-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells
- (2010) Maika Almstedt et al. LEUKEMIA RESEARCH
- Combinations of DNA Methyltransferase and Histone Deacetylase Inhibitors Induce DNA Damage in Small Cell Lung Cancer Cells: Correlation of Resistance with IFN-Stimulated Gene Expression
- (2010) Wioleta Luszczek et al. MOLECULAR CANCER THERAPEUTICS
- S110, a 5-Aza-2'-Deoxycytidine-Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In vivo and Can Reduce Tumor Growth
- (2010) J. C. Chuang et al. MOLECULAR CANCER THERAPEUTICS
- Epigenetic silencing of TNFSF7 (CD70) by DNA methylation during progression to breast cancer
- (2010) Seung Eun Yu et al. MOLECULES AND CELLS
- Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: A children's oncology group study
- (2010) Rani E. George et al. PEDIATRIC BLOOD & CANCER
- Effect of 5-Aza-2’-deoxycytidine on immune-associated proteins in exosomes from hepatoma
- (2010) Wen-Hua Xiao WORLD JOURNAL OF GASTROENTEROLOGY
- Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors
- (2010) Lisa A Cowan et al. Epigenomics
- Decitabine Effect on Tumor Global DNA Methylation and Other Parameters in a Phase I Trial in Refractory Solid Tumors and Lymphomas
- (2009) D. J. Stewart et al. CLINICAL CANCER RESEARCH
- Quantitative expression and immunogenicity of MAGE-3 and -6 in upper aerodigestive tract cancer
- (2009) Pedro A. Andrade Filho et al. INTERNATIONAL JOURNAL OF CANCER
- A Systematic Assessment of Radiation Dose Enhancement by 5-Aza-2′-Deoxycytidine and Histone Deacetylase Inhibitors in Head-and-Neck Squamous Cell Carcinoma
- (2009) Harlinde De Schutter et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
- (2009) T. B. Miranda et al. MOLECULAR CANCER THERAPEUTICS
- Treatment with demethylating agent, 5-aza-2′-deoxycytidine enhances therapeutic HPV DNA vaccine potency
- (2009) Dan Lu et al. VACCINE
- The combination effect of sodium butyrate and 5-Aza-2'-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines
- (2009) Hang Cho et al. World Journal of Surgical Oncology
- Treatment of ovarian cancer cell lines with 5-aza-2′-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules
- (2008) Sara J. Adair et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- DNA methyltransferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells
- (2008) Hong Qiu et al. CANCER SCIENCE
- Intertumor and Intratumor NY-ESO-1 Expression Heterogeneity Is Associated with Promoter-Specific and Global DNA Methylation Status in Ovarian Cancer
- (2008) A. Woloszynska-Read et al. CLINICAL CANCER RESEARCH
- DNA Methylation: Its Role in Cancer Development and Therapy
- (2008) C. Kurkjian et al. CURRENT PROBLEMS IN CANCER
- DNA methylation changes in ovarian cancer: Implications for early diagnosis, prognosis and treatment
- (2008) Caroline A. Barton et al. GYNECOLOGIC ONCOLOGY
- The DNA demethylating agent 5-aza-2′-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma
- (2008) Atsushi Natsume et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistic induction of NY-ESO-1 antigen expression by a novel histone deacetylase inhibitor, valproic acid, with 5-aza-2′-deoxycytidine in glioma cells
- (2008) Sachie Oi et al. JOURNAL OF NEURO-ONCOLOGY
- Demethylating agent 5-aza-2′-deoxycytidine activates HLA-G expression in human leukemia cell lines
- (2008) K. Poláková et al. LEUKEMIA RESEARCH
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started